Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Increase in Short Interest

Posted by Patrick Bannon on Jul 11th, 2026

Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 46,964 shares, an increase of 2,398.1% from the June 15th total of 1,880 shares. Based on an average daily volume of 83,081 shares, the short-interest ratio is currently 0.6 days. Approximately 0.0% of the shares of the stock are sold short.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. BMO Capital Markets initiated coverage on Straumann in a report on Wednesday. They issued an “outperform” rating on the stock. Citigroup restated a “sell” rating on shares of Straumann in a research report on Thursday. Barclays reaffirmed an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. Finally, Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold”.

View Our Latest Research Report on Straumann

Straumann Trading Up 1.4%

SAUHY stock traded up $0.18 during midday trading on Friday, reaching $13.03. 78,950 shares of the stock were exchanged, compared to its average volume of 37,098. Straumann has a 52 week low of $9.44 and a 52 week high of $14.11. The company has a fifty day moving average price of $11.97 and a 200 day moving average price of $11.65.

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.